PPMD 2018 Conference - Restoring or Replacing Dystrophin

The 2018 PPMD Annual Conference marks the 24th time families, physicians, researchers, caregivers, industry partners, and those living with Duchenne have gathered to discuss all topics Duchenne.

This conference is like no other. Here, the key is community. All the pieces of this incredible community come together to learn, to listen, and to look forward at driving change. Every single voice is important, and every moment is rich. Now is the time for us to come together as a community and seize this moment.

The field is ripe with opportunity and at the PPMD Annual Conference partnerships are built, questions are asked and answered, and friendships are forged.

0:00:00 - Intro to session – Restoring or Replacing Dystrophin - Moderator: Abby Bronson

0:00:59 - NS Pharma - Paula Clemens, MD - Hirofumi Komaki, MD

0:20:47 - WAVE Life Sciences - Wendy Erler, VP Patient Adv.

0:39:20 - Sarepta Therapeutics - Doug Ingram, CEO

1:01:37 - Summit, Plc - Michelle Avery, PhD

1:05:29 - PTC Therapeutics - Stuart Peltz, CEO

1:22:44 - Q&A followed by Polling Time #1